Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23828223 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of HQK-1001 in Patients With Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia;   Sickle Cell Disorders;   Hemoglobin S Disease;   Sickling Disorder Due to Hemoglobin S
Intervention: Drug: HQK-1001

Indicates status has not been verified in more than two years